| 2008 |
HUWE1 ubiquitinates N-Myc via K48-linked polyubiquitin chains, targeting it for proteasomal degradation; genetic and RNAi-mediated inactivation of Huwe1 stabilizes N-Myc, prevents cell-cycle exit, and blocks neuronal differentiation in ES cells and mouse brain cortex. |
Co-IP, in vitro ubiquitination assay, genetic knockout, RNAi knockdown in ES cells and mouse brain with phenotypic rescue by N-myc silencing |
Nature cell biology |
High |
18488021
|
| 2005 |
The HECT domain of HUWE1 (hUREB1) ubiquitinates p53 and promotes its proteasomal degradation, suppressing p53 transcriptional activity; point mutations abolishing HECT catalytic activity block this effect. |
Transient transfection overexpression, p53 reporter assay, MG132 proteasome inhibition, HECT domain deletion/point mutation analysis |
Biochemical and biophysical research communications |
Medium |
15567145
|
| 2007 |
HUWE1 directly binds Cdc6 and polyubiquitinates it in vitro; Huwe1 is required for Cdc6 degradation after UV or MMS-induced DNA damage, and this function is conserved (yeast ortholog Tom1 performs the same role). |
Co-IP, in vitro polyubiquitination assay, siRNA knockdown, yeast genetic analysis |
Molecular biology of the cell |
High |
17567951
|
| 2009 |
The N-terminal helix of the HUWE1 HECT domain structurally stabilizes the domain and modulates activity: its absence increases self-ubiquitination while having distinct effects on substrate (Mcl-1) ubiquitination, revealing a structural element that differentially controls self- vs. substrate-ubiquitination. |
Crystal structure determination, deletion mutagenesis, in vitro self-ubiquitination and substrate ubiquitination assays |
The Journal of biological chemistry |
High |
20007713
|
| 2009 |
Huwe1 operates upstream of the N-Myc–DLL3–Notch pathway in the developing brain; conditional Huwe1 knockout causes N-Myc accumulation, DLL3 elevation, and Notch suppression, resulting in neural stem cell over-expansion and failure of neurogenesis. |
Conditional knockout mouse, gain- and loss-of-function experiments in mouse cortex, epistasis analysis |
Developmental cell |
High |
19686682
|
| 2010 |
Huwe1 loss in cerebellar granule neuron precursors causes N-Myc accumulation and uncontrolled proliferation; additional loss in Bergmann glia disrupts glial differentiation and granule neuron migration, demonstrating Huwe1 coordinates neuronal and glial programming. |
Conditional knockout mouse (cerebellar-specific), immunohistochemistry, N-Myc protein level assessment |
Proceedings of the National Academy of Sciences of the United States of America |
High |
20231446
|
| 2010 |
The C. elegans HUWE1 ortholog EEL-1 fine-tunes myotactin (hemidesmosome ECM receptor) abundance ~2-fold; EEL-1 activity is essential for hemidesmosomes to mature into a tension-resistant form during embryonic development. |
Genome-wide RNAi screen in C. elegans, quantitative protein level analysis, genetic interaction with plakin mutant |
Current biology : CB |
Medium |
20153198
|
| 2012 |
HUWE1 ubiquitinates MyoD at its N-terminal residue and targets it for proteasomal degradation, acting as an E3 ligase for this muscle-regulatory transcription factor. |
In vitro ubiquitination assay, proteasome inhibitor treatment, co-IP |
Biochemical and biophysical research communications |
Medium |
22277673
|
| 2012 |
HUWE1 is associated with the UFD substrate Ub(G76V)-YFP and the 26S proteasome; HUWE1 knockdown stabilizes ubiquitin-fusion degradation (UFD) substrates and the pathological UFD substrate UBB+1; HUWE1 and TRIP12 function in parallel to degrade UFD substrates. |
High-throughput siRNA imaging screen, co-IP with proteasome, substrate half-life analysis, double knockdown epistasis |
PloS one |
Medium |
23209776
|
| 2012 |
ARF-BP1/HUWE1 forms a multiprotein complex with ARF, p53, MYC, and CTCF; HUWE1 ubiquitylates CTCF leading to its proteasomal degradation, linking the MYC proliferative and p53-ARF apoptotic pathways. |
Co-immunoprecipitation, ubiquitination assay, siRNA knockdown with apoptosis/growth arrest readout |
International journal of molecular sciences |
Medium |
22754359
|
| 2013 |
HUWE1 ubiquitylates the antiapoptotic factor Mcl-1; MDM2 ubiquitylates HUWE1 itself; in HER2+ breast cancer cells treated with lapatinib, MDM2 degradation stabilizes HUWE1 enabling Mcl-1 degradation and apoptosis, while lapatinib-resistant cells maintain MDM2 to degrade HUWE1. |
Co-IP, ubiquitination assay, siRNA knockdown, xenograft models, half-life analysis |
Science signaling |
Medium |
23652204
|
| 2013 |
In Ras-driven skin tumorigenesis, Mule/HUWE1 suppresses tumor formation by preventing accumulation of c-Myc/Miz1 transcriptional complexes that otherwise downregulate p21 and p15; genetic knockout of c-Myc (but not p53 or p19Arf) reverses the Mule-KO tumorigenic phenotype. |
Conditional knockout mouse (K14Cre), chemical carcinogenesis model, genetic epistasis (c-Myc, p53, p19Arf co-knockouts), Miz1 knockdown rescue |
Genes & development |
High |
23699408
|
| 2014 |
Huwe1 ubiquitylates Dishevelled (Dvl) with K63-linked polyubiquitin chains in a Wnt3a- and CK1ε-dependent manner; this inhibits Dvl DIX-domain multimerization required for Wnt signaling, creating a negative feedback loop upstream of β-catenin and downstream of CK1/LRP6. |
RNAi screen in C. elegans, reporter assay in HEK293T cells, co-IP, mass spectrometry for K63-linkage determination, Dvl multimerization assay |
Science signaling |
High |
24643799
|
| 2014 |
HUWE1 ubiquitylates and degrades TIAM1 preferentially at cell-cell adhesions in response to HGF, facilitating junction disassembly, cell scattering, migration, and invasion; simultaneous TIAM1 depletion rescues migration/invasion in HUWE1-depleted cells. |
Co-IP, ubiquitination assay, siRNA knockdown, HGF stimulation assays, invasion assay, epistasis (TIAM1 double depletion), human lung cancer cell validation |
Cell reports |
High |
25543140
|
| 2014 |
HUWE1 binds Shoc2 and mediates its ubiquitination and degradation; HUWE1 also controls RAF-1 ubiquitination and its kinase levels through the Shoc2 scaffold; HUWE1 depletion abolishes RAF-1 ubiquitination, altering ERK1/2 pathway activity. |
Co-IP, ubiquitination assay, siRNA knockdown, ERK1/2 activity measurement |
Molecular and cellular biology |
Medium |
25022756
|
| 2014 |
HUWE1 is required for growth of colorectal cancer cells; HUWE1 associates with both MYC and MIZ1; HUWE1 inhibition stabilizes MIZ1, which accumulates on MYC target genes and represses MYC-activated transcription, revealing that continuous MIZ1 degradation is required for MYC transactivation. |
Small-molecule HUWE1 inhibitors (high-throughput screen), genetic knockdown, gene expression analysis, orthotopic xenograft models |
EMBO molecular medicine |
High |
25253726
|
| 2014 |
HUWE1 degrades DDIT4 (REDD1) through ubiquitination; diGly proteomics coupled with inducible HUWE1 RNAi identified DDIT4 as a HUWE1 substrate; HUWE1 interacts with and regulates DDIT4 stability in cell-based assays. |
Inducible RNAi, quantitative diGly (ubiquitin remnant) proteomics, co-IP, protein half-life assay |
The Journal of biological chemistry |
Medium |
25147182
|
| 2014 |
Huwe1 phosphodependently degrades the transcription factor Atoh1; SHH signaling prevents this phosphodependent degradation, stabilizing Atoh1 to promote neuronal precursor expansion; Huwe1 loss in mouse SHH medulloblastoma disrupts this developmental mechanism. |
In vivo mouse cerebellar studies, genetic Huwe1 loss-of-function, phosphorylation analysis, protein stability assay |
Developmental cell |
Medium |
24960692
|
| 2015 |
HUWE1 mediates K48-linked polyubiquitination of Atoh1 following CK1-mediated phosphorylation at serine 334; this targets Atoh1 for proteasomal degradation; Huwe1 knockout in cochlear-supporting cells causes extra inner hair cells and synaptic defects. |
Co-IP, proximity ligation assay, mass spectrometry, cell-free ubiquitination system, CK1 inhibition, Huwe1 conditional knockout in cochlea |
The Journal of biological chemistry |
High |
27542412
|
| 2015 |
ATM kinase, SIRT6, and SNF2H cooperate to block HUWE1-mediated poly-ubiquitination of H2AX upon DSB formation, transiently stabilizing H2AX to allow efficient γH2AX foci formation and chromatin incorporation; ATM phosphorylation of H2AX Ser139 is essential for this stabilization. |
Proteasome inhibition, ubiquitination assay, siRNA knockdown of HUWE1/ATM/SIRT6/SNF2H, γH2AX foci analysis, Ser139 mutation |
Cell reports |
High |
26711340
|
| 2015 |
DNA damage activates CUL4B, which ubiquitinates HUWE1 in a NEDD8-dependent manner, targeting HUWE1 for proteasomal degradation; CUL4B depletion stabilizes HUWE1, accelerating MCL-1 degradation and increasing apoptosis, which is rescued by simultaneous HUWE1 depletion. |
Co-IP, in vitro ubiquitination assay, NEDD8 inhibition, CUL4B siRNA knockdown, epistasis with HUWE1 |
Nucleic acids research |
High |
25883150
|
| 2015 |
HUWE1 and NEDD4-1 are E3 ligases for ABCG1 and ABCG4; silencing both ligases increases ABCG1/ABCG4 protein levels and cholesterol export; overexpression of either ligase reduces transporter levels. |
LC-MS identification of ligases, siRNA silencing, overexpression, cholesterol export assay |
The Journal of biological chemistry |
Medium |
26296893
|
| 2016 |
HUWE1 ubiquitinates unassembled soluble proteins bearing hydrophobic segments in the cytoplasm; this requires p97/NPL4; inhibition of nuclear entry enhances HUWE1-mediated ubiquitination, placing USPD primarily in the cytoplasm; SILAC proteomics identified nuclear complex subunits as endogenous HUWE1 substrates. |
Stable isotope labeling (SILAC) proteomics, in vitro ubiquitination, p97 inhibition, nuclear import inhibition |
Cell discovery |
High |
27867533
|
| 2016 |
HUWE1 is essential for replication of damaged DNA; HUWE1-knockout cells fail to mitigate replication stress; HUWE1 interacts with PCNA at stalled replication forks and mono-ubiquitinates H2AX to promote signaling at these sites. |
HUWE1 knockout cells, replication stress assays, co-IP with PCNA, H2AX ubiquitination assay, DNA fiber analysis |
EMBO reports |
High |
27146073
|
| 2016 |
Huwe1 is essential for HSC self-renewal, quiescence, and lymphoid-fate specification by post-translationally controlling N-myc; N-myc levels are upregulated after Huwe1 loss or stress, leading to HSC exhaustion; Mycn depletion reverses most Huwe1-KO phenotypes in vivo. |
Conditional knockout mouse, fluorescent Mycn fusion allele (live imaging), genetic rescue by Mycn deletion |
Nature immunology |
High |
27668798
|
| 2017 |
HUWE1 is a bona fide tumor suppressor in intestinal epithelium; identified mutations in colorectal cancer inactivate HUWE1 E3 ligase activity; Huwe1 deletion accelerates APC-loss-driven tumorigenesis through increased MYC levels and rapid DNA damage accumulation, leading to loss of the second APC allele. |
Modeling of clinical mutations in cells, conditional knockout in Apc-mutant mice, MYC protein level analysis, comet assay, epistasis with MCL1 |
EMBO molecular medicine |
High |
28003334
|
| 2017 |
HUWE1 mediates UV-induced polyubiquitination of histone H1 at multiple lysines; HUWE1-depleted cells show reduced RNF168 and 53BP1 recruitment to DNA damage sites (downstream of RNF8-mediated H1 ubiquitination) but normal MDC1 recruitment (upstream); HUWE1 primes H1 to allow K63-chain elongation by RNF8. |
Quantitative diGly proteomics, siRNA knockdown, recruitment assays (RNF168, 53BP1, MDC1) at DNA damage sites |
Scientific reports |
Medium |
29127375
|
| 2017 |
HUWE1 forms an auto-inhibited asymmetric dimer in solution and in cells through a crystallographic dimer interface; disruption of the dimer activates HUWE1; a conserved intramolecular segment counteracts dimerization; tumor suppressor p14ARF binds this segment and may shift HUWE1 toward the inactive state. |
Crystal structure determination, solution dimerization assays (biochemical), cellular self-association assays, HUWE1 activation upon dimer disruption, ARF binding experiment |
eLife |
High |
28193319
|
| 2017 |
HUWE1 ubiquitinates histone H1.3, targeting it for proteasomal degradation; Huwe1-deficient cells accumulate H1.3, which silences H19 expression; H1.3 silencing partially rescues H19 expression and the Huwe1-null phenotype in ovarian epithelial transformation. |
Co-IP, ubiquitination assay, Huwe1 conditional knockout in mice, H1.3/H19 epistasis analysis |
Cancer research |
Medium |
28687618
|
| 2018 |
HUWE1 promotes PINK1/PARKIN-independent mitophagy by enabling IKKα-mediated phosphorylation of AMBRA1 at serine 1014, which induces structural changes in AMBRA1 promoting its interaction with LC3/GABARAP proteins and mitophagic activity. |
Co-IP, siRNA knockdown, phosphorylation mutant analysis, mitophagy assays, IKKα kinase identification |
Nature communications |
High |
30217973
|
| 2018 |
mTORC1 phosphorylates WIPI2 at Ser395, directing it to interact specifically with HUWE1 for ubiquitination and proteasomal degradation; HUWE1 loss stabilizes WIPI2, enhances autophagosome formation, and improves hepatic lipid clearance in fasting mice. |
In vitro mTORC1 phosphorylation assay, co-IP, ubiquitination assay, HUWE1 siRNA in mouse liver, WIPI2 stabilization and autophagy flux measurement |
Molecular cell |
High |
30340022
|
| 2018 |
HUWE1 promotes ubiquitination and proteasomal degradation of PPARα in coordination with the scaffold protein PAQR3; PAQR3 directly interacts with PPARα and enhances the PPARα–HUWE1 interaction; PAQR3 deficiency in liver increases PPARα-target gene expression during fasting. |
Co-IP, polyubiquitination assay, adenoviral knockdown/liver-specific KO of PAQR3, PPARα target gene expression, fasting metabolic assays |
Hepatology |
Medium |
29331071
|
| 2018 |
HUWE1 controls lung cancer cell malignancy by promoting proteasomal degradation of p53; HUWE1 inactivation increases p53, upregulates p21 and downregulates HIF1α; Huwe1 conditional deletion abolishes EGFRVIII-induced lung cancer in mice. |
siRNA/shRNA knockdown, soft agar and xenograft assays, western blot for p53/p21/HIF1α, genetically engineered Huwe1 conditional KO mouse |
Theranostics |
Medium |
30026863
|
| 2019 |
HUWE1 controls AMBRA1-mediated mitophagy through MCL1 stability: MCL1 overexpression inhibits HUWE1 recruitment to mitochondria during AMBRA1-induced mitophagy; GSK-3β phosphorylates MCL1 at S159, which triggers HUWE1-dependent MCL1 degradation, enabling mitophagy to proceed. |
Co-IP, overexpression/knockdown, GSK-3β inhibitor treatment, phosphorylation site mutagenesis, mitophagy assays |
Cell death and differentiation |
Medium |
31434979
|
| 2019 |
HUWE1 directly ubiquitinates Chk1 at multiple lysines within the kinase domain, controlling Chk1 protein stability; HUWE1 knockdown prolongs Chk1 half-life and elevates Chk1 levels independently of ATM/ATR and p53; replication stress reduces Chk1 levels in a HUWE1-dependent manner. |
HUWE1 siRNA knockdown, in vitro ubiquitination assay with lysine mapping, Chk1 half-life measurement, replication stress (HU, camptothecin) |
The FEBS journal |
Medium |
31713291
|
| 2020 |
HUWE1 interacts with AIM2, NLRP3, and NLRC4 through specific domain interactions (BH3 domain of HUWE1; HIN domain of AIM2; NACHT domains of NLRP3/NLRC4); HUWE1 mediates K27-linked polyubiquitination of these inflammasome sensors, promoting inflammasome assembly, ASC speck formation, and caspase-1 activation. |
Co-IP, domain-mapping experiments, ubiquitination assay (K27 linkage), HUWE1-KO macrophages, HUWE1 inhibitor (BI8622), in vivo bacterial infection models |
The Journal of clinical investigation |
High |
33104527
|
| 2020 |
HUWE1-dependent neddylation of DNA-PKcs at its kinase domain, catalyzed by E2 UBE2M, is required for DNA-PKcs autophosphorylation at Ser2056 and efficient NHEJ repair. |
Co-IP, neddylation assay, HUWE1 siRNA, DNA-PKcs autophosphorylation assay, NHEJ efficiency measurement |
Cell death & disease |
Medium |
32457294
|
| 2020 |
HAPSTR1 (C16orf72) is required for HUWE1 nuclear localization; nuclear HUWE1 is needed for cell proliferation and modulation of p53 and NF-κB stress signaling pathways; unbiased quantitative proteomics shows HUWE1 substrate targeting is largely cell-type-specific. |
Quantitative proteomics, HAPSTR1 KO, subcellular fractionation, p53/NF-κB reporter assays |
Cell reports |
High |
37167062
|
| 2021 |
Cryo-EM structures of full-length HUWE1 reveal an alpha-solenoid assembly with a central pore decorated with protein interaction modules; the N-terminal ~3900 amino acids are indispensable for proper ligase function; neurodevelopmental disorder-associated variants and substrate binding were mapped onto the three-dimensional organization. |
Cryo-EM structure determination, functional analysis of deletion constructs, structure of disease-variant HUWE1 and substrate-bound complex |
Molecular cell |
High |
34314700
|
| 2021 |
Crystal structure of Nematocida HUWE1 reveals a snake-like alpha-solenoid ring with the C-terminal HECT domain at the head; the ring structure is highly dynamic, allowing the flexible HECT domain to access substrate-presenting acceptor sites distributed around the ring; this explains how HUWE1 ubiquitinates diverse unrelated substrates. |
Crystal structure determination, integrative structural analysis, functional validation of ring architecture |
Nature chemical biology |
High |
34294896
|
| 2021 |
HUWE1 ubiquitinates ATG101 for proteasomal degradation; HUWE1-depleted cells have stable ATG101 and elevated autophagy; HUWE1 thus suppresses autophagy flux by targeting both WIPI2 and ATG101. |
CRISPR KO of ATG101, co-IP, siRNA knockdown, autophagy assays, ATG101 domain mapping of ubiquitination site |
International journal of molecular sciences |
Medium |
34502089
|
| 2022 |
HUWE1 directly ubiquitinates transferrin receptor 1 (TfR1) for proteasomal degradation, thereby regulating cellular iron metabolism; Huwe1 hepatocyte-specific knockout leads to TfR1 accumulation, excess iron uptake, lipid peroxidation, and ferroptosis in acute liver injury models. |
Hepatocyte-specific Huwe1 KO mice, ubiquitination assay, TfR1 protein level analysis, ferroptosis markers, chemical/genetic TfR1 inhibition rescue |
Cell death and differentiation |
High |
35260822
|
| 2022 |
HUWE1 promotes ubiquitination and degradation of EGFR; HUWE1 physically interacts with EGFR; HUWE1 overexpression decreases EGFR levels and protects against TGF-β-induced renal tubular injury. |
Co-IP, ubiquitination assay, overexpression/knockdown in HK-2 cells, UUO mouse model |
FASEB journal |
Medium |
32017279
|
| 2023 |
HUWE1 controls TTP (tristetraprolin) stability indirectly by regulating its phosphorylation; HUWE1 function requires phosphatase and E3 ligase binding sites in the TTP C-terminus; HUWE1-regulated phosphorylation is independent of MAPK-mediated S52/S178 phosphorylation and controls TTP stability at late stages of pro-inflammatory stimulation. |
Genetic screen, pharmacological kinase inhibition, TTP phosphorylation analysis, stability assays, domain-mapping |
eLife |
Medium |
36961408
|
| 2024 |
HUWE1 acts as a centrosomal E3 ligase targeting TTBK2 for degradation; TTBK2 stabilizes primary cilia and promotes GNP proliferation in response to SHH; HUWE1-mediated TTBK2 degradation triggers primary cilia disassembly, thereby driving GNP differentiation and migration in cerebellar development. |
Conditional knockout mouse (cerebellar GNPs), co-IP, ubiquitination assay, TTBK2 overexpression/depletion, primary cilia dynamics assay |
Cell death and differentiation |
High |
38879724
|
| 2024 |
CDK9 recruits HUWE1 to ubiquitinate and degrade RARα; pharmacological CDK9 inhibition stabilizes RARα and synergizes with ATRA in suppressing CTCL tumor growth. |
Co-IP (CDK9–HUWE1 interaction), RARα ubiquitination assay, CDK9 PROTAC, in vitro and xenograft combination treatment |
Nature communications |
Medium |
39632829
|
| 2023 |
HUWE1 possesses a Ubiquitin-Directed ubiquitin Ligase (UDL) activity: it recognizes substrates and aggregates/condensates bearing high-density pre-existing ubiquitin chains and amplifies ubiquitin modifications on them; this recruits p97/VCP for processing and downstream proteasomal or autophagic clearance. |
Biochemical reconstitution, aggregate clearance assays, p97 co-recruitment assay, cell-cycle transition analysis |
bioRxivpreprint |
Medium |
37398461
|
| 2014 |
HUWE1 interacts with and promotes proteasomal degradation of BRCA1 via the ubiquitin-proteasome pathway; HUWE1 binds BRCA1 through an N-terminal degron domain; HUWE1 depletion increases BRCA1 levels and resistance to ionizing radiation and mitomycin. |
Co-IP, siRNA knockdown, BRCA1 half-life assay, clonogenic survival after IR/mitomycin |
Biochemical and biophysical research communications |
Medium |
24342616 24472556
|
| 2018 |
CRL4B E3 ligase with the DCAF adaptor RBBP7 polyubiquitinates HUWE1 and targets it for proteasomal degradation; RBBP7 depletion stabilizes HUWE1 and accelerates MCL-1 and BRCA1 degradation. |
Co-IP identifying RBBP7 as DCAF, in vitro ubiquitination assay, RBBP7 overexpression/depletion, MCL-1/BRCA1 levels |
Biochemical and biophysical research communications |
Medium |
29738775
|
| 2019 |
HUWE1 ubiquitinates the GlyR-α1 subunit of glycine receptors in the spinal cord dorsal horn, reducing surface expression of GlyRs via endocytosis; HUWE1 knockdown blunts GlyR-α1 ubiquitination, potentiates glycinergic transmission, and attenuates inflammatory pain in mice. |
Co-IP (HUWE1–GlyR-α1 interaction), ubiquitination assay, shRNA knockdown in dorsal horn, surface expression assay, electrophysiology, CFA pain model |
Neuropharmacology |
High |
30721695
|
| 2020 |
HUWE1 also functions as an E3 ligase for Ezh1α (PRC2 complex component): reduced HUWE1 association is required for Ezh1α stabilization under oxidative stress in skeletal muscle cells. |
Co-IP, ubiquitination assay, kinase inhibition of Ser560 phosphorylation on Ezh1β |
Epigenetics & chromatin |
Low |
31856907
|
| 2021 |
HUWE1 ubiquitinates Ets-1 transcription factor for proteasomal degradation; this interaction is regulated by Ets-1 Thr38 phosphorylation status; HUWE1-mediated Ets-1 degradation reduces Treg cell differentiation and function, causing immune imbalance in ITP. |
Co-IP, cycloheximide-chase assay, ubiquitination assay, Thr38 phosphorylation analysis, HUWE1 overexpression/knockdown, in vivo ITP mouse model with HUWE1 inhibitor |
Frontiers in cell and developmental biology |
Medium |
34900980
|
| 2013 |
Increased HUWE1 dosage in Drosophila (modeling human duplication) decreases Dishevelled (dsh) protein levels ~50% and causes axon branching defects in dorsal cluster neurons; fz2 and dsh mutants phenocopy this; constitutively active β-catenin (armadillo) partially rescues, placing HUWE1 upstream of Wnt/β-catenin in axon development. |
Drosophila overexpression model, protein level quantification, genetic epistasis with dsh/fz2/armadillo mutants |
PloS one |
Medium |
24303071
|
| 2022 |
HUWE1 ubiquitinates TOMM20 directly and also regulates TOMM20 degradation via a PARKIN-mediated pathway; HUWE1 overexpression impairs mitochondrial ATP production and membrane potential, increasing ROS and apoptosis, sensitizing CRC cells to oxaliplatin. |
Co-IP, ubiquitination assay, mitochondrial function assays (ATP, membrane potential), HUWE1 overexpression, oxaliplatin sensitivity assay |
Oncogene |
Medium |
38184713
|
| 2025 |
HUWE1 ubiquitinates and degrades MUTYH (DNA repair glycosylase) in renal tubular epithelial cells; upregulation of HUWE1 during AKI causes MUTYH depletion, leading to 8-oxoG accumulation, mitochondrial dysfunction, and tubular injury; HUWE1 KO or BI8622 treatment protects against cisplatin-induced AKI. |
Co-IP, ubiquitination assay, HUWE1 KO mice, BI8622 pharmacological inhibition, cisplatin/FA AKI models, 8-oxoG quantification, mitochondrial function assays |
Advanced science |
Medium |
39921445
|
| 1995 |
UREB1 (HUWE1) inhibits p53 transcriptional activity when co-expressed; this inhibitory effect requires tyrosine phosphorylation of UREB1, as a tyrosine-to-alanine mutation in the phosphorylation site significantly attenuates suppression. |
Transient co-transfection in p53-null H1299 cells, p53 reporter assay, tyrosine phosphorylation site mutagenesis |
Oncogene |
Low |
7478539
|